Could AI's Universal Coronavirus Vaccine Strategy Lead To An Ebola Breakthrough?

Could AI's Universal Coronavirus Vaccine Strategy Lead To An Ebola Breakthrough?

Credit-Canva

Text

Updated Jun 7, 2026 | 07:00 PM IST

SummaryThe University of Cambridge and the company DIOSynVax have completed the human clinical trial of a universal coronavirus vaccine by using only artificial intelligence (AI) and machine learning.

End of Article